The Larvol Group to Participate in the Pharma CI Conference & Exhibition Europe

Top Quote The Larvol Group from San Francisco CA is going to Participate in the Pharma CI Conference & Exhibition in Europe. End Quote
  • San Francisco, CA (1888PressRelease) February 16, 2012 - The Larvol Group, LLC, a San Francisco-based competitive intelligence company, announced today that it will participate in the upcoming Pharma CI Conference & Exhibition on February 21st and 22nd in Zurich, Switzerland as both a sponsor and exhibitor. Company President, Bruno Larvol, will also be speaking at the conference. He will discuss the challenges that pharmaceutical companies face when attempting to monitor large volumes of secondary competitive intelligence information including news, corporate communication, conferences, trials, financial analyst reports and product milestones. Mr. Larvol will explore numerous options for mapping out competitor landscape activity and monitoring clinical trial and milestone developments . Mr. Larvol will present lessons learned from The Larvol Group's experience in providing the industry with customized, integrated market intelligence reports.

    About The Larvol Group:
    The Larvol Group, LLC, ( founded in 2004, provides innovative business intelligence services for the pharmaceutical industry. Their Market Intelligence Reports track relevant news, clinical trials and developments in the competitive landscape of a given indication. Drawing on the knowledge of over 100 professionals, The Larvol Group has expertise in all major therapeutic areas, including oncology, metabolic diseases, CNS, inflammation, cardiovascular, and pain management. Their customers include nine of the top 10 pharmaceutical companies.

    For more information regarding this topic or to schedule an interview with Bruno Larvol, please contact Brandi Lambert at brandi.lambert ( @ ) larvol dot com or 816.665.7641.

  • FB Icon Twitter Icon In-Icon
Contact Information